+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033 - Product Thumbnail Image

Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033

  • Report
  • January 2025
  • 375 Pages
  • Global
From
InterLeukin6 IL6 Inhibitor Market 2024 - Product Thumbnail Image

InterLeukin6 IL6 Inhibitor Market 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
Epinephrine Autoinjector Market Report by Dosage, Application, End User, and Region 2025-2033 - Product Thumbnail Image

Epinephrine Autoinjector Market Report by Dosage, Application, End User, and Region 2025-2033

  • Report
  • January 2025
  • 124 Pages
  • Global
From
Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2024-2032 - Product Thumbnail Image

Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2024-2032

  • Report
  • September 2024
  • 140 Pages
  • Global
From
Autoimmune Disease Diagnosis Market Report by Product Type, Disease Type, Test Type, End-User, and Region 2024-2032 - Product Thumbnail Image

Autoimmune Disease Diagnosis Market Report by Product Type, Disease Type, Test Type, End-User, and Region 2024-2032

  • Report
  • August 2024
  • 142 Pages
  • Global
From
Primary Immunodeficiency Disorders Market Size, Share and Trends Analysis Report by Disease (Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders), Treatment, and Region 2024-2030 - Product Thumbnail Image

Primary Immunodeficiency Disorders Market Size, Share and Trends Analysis Report by Disease (Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders), Treatment, and Region 2024-2030

  • Report
  • September 2024
  • 150 Pages
  • Global
From
Food Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Allergen Source, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Food Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Allergen Source, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • July 2024
  • 100 Pages
  • Global
From
Sodium Hyaluronate-based Products - Global Strategic Business Report - Product Thumbnail Image

Sodium Hyaluronate-based Products - Global Strategic Business Report

  • Report
  • May 2025
  • 73 Pages
  • Global
From
Chemotherapy-Induced Alopecia Treatment Devices - Global Strategic Business Report - Product Thumbnail Image

Chemotherapy-Induced Alopecia Treatment Devices - Global Strategic Business Report

  • Report
  • May 2025
  • 470 Pages
  • Global
From
Graft Versus Host Disease (GvHD) Treatment - Global Strategic Business Report - Product Thumbnail Image

Graft Versus Host Disease (GvHD) Treatment - Global Strategic Business Report

  • Report
  • May 2025
  • 296 Pages
  • Global
From
Allergic Rhinitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Allergic Rhinitis Drugs - Global Strategic Business Report

  • Report
  • May 2025
  • 563 Pages
  • Global
From
Methotrexate Drugs - Global Strategic Business Report - Product Thumbnail Image

Methotrexate Drugs - Global Strategic Business Report

  • Report
  • May 2025
  • 564 Pages
  • Global
From
Bispecific Antibodies - Global Strategic Business Report - Product Thumbnail Image

Bispecific Antibodies - Global Strategic Business Report

  • Report
  • May 2025
  • 104 Pages
  • Global
From
Immunotoxins - Global Strategic Business Report - Product Thumbnail Image

Immunotoxins - Global Strategic Business Report

  • Report
  • May 2025
  • 377 Pages
  • Global
From
Polyclonal Antibodies - Global Strategic Business Report - Product Thumbnail Image

Polyclonal Antibodies - Global Strategic Business Report

  • Report
  • May 2025
  • 63 Pages
  • Global
From
Ibuprofen API - Global Strategic Business Report - Product Thumbnail Image

Ibuprofen API - Global Strategic Business Report

  • Report
  • May 2025
  • 139 Pages
  • Global
From
Hydroxychloroquine - Global Strategic Business Report - Product Thumbnail Image

Hydroxychloroquine - Global Strategic Business Report

  • Report
  • May 2025
  • 293 Pages
  • Global
From
Chemotherapy-Induced Neutropenia Treatment - Global Strategic Business Report - Product Thumbnail Image

Chemotherapy-Induced Neutropenia Treatment - Global Strategic Business Report

  • Report
  • May 2025
  • 381 Pages
  • Global
From
Epidermolysis Bullosa Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Epidermolysis Bullosa Therapeutics - Global Strategic Business Report

  • Report
  • May 2025
  • 121 Pages
  • Global
From
Autoimmune Hemolytic Anemia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Hemolytic Anemia Therapeutics - Global Strategic Business Report

  • Report
  • May 2025
  • 197 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more